Please try another search
Haleon Pakistan Limited engages in the research and development, manufacture, marketing, and sale of consumer healthcare products primarily in Pakistan. The company offers products in the areas of pain relief under the Panadol brand; oral health under the Sensodyne and Parodontax brand names; respiratory health under the Panadol CF, Sancos, T-Day, Tandegyl, and Actified brands; nutrition and gastrointestinal health under the CaC-1000 PLUS, ENO, and QalSium-D brand names; and skin health under the Physiogel, Hydrozole, SunBlock 60, Lamisil, Acne Aid, Duofilm, SpectraBan, Brevoxyl, and Oilatum brands. It also exports its products. The company was incorporated in 2015 and is headquartered in Karachi, Pakistan. The company was formerly known as GlaxoSmithKline Consumer Healthcare Pakistan Limited and changed its name to Haleon Pakistan Limited in January 2023. Haleon Pakistan Limited operates as a subsidiary of Glaxosmithkline Consumer Healthcare B.V.
Name | Age | Since | Title |
---|---|---|---|
Farhan Muhammad Haroon | - | 2021 | CEO & Executive Director |
Muhammad Zindah Moin Mohajir | - | 2018 | Independent Chairperson of the Board |
Sumru Atalay Besceli | - | 2022 | Non-Executive Director |
Dilawar Meghani | - | 2020 | Finance Director, CFO & Executive Director |
Syed Anwar Mahmood | - | 2016 | Independent Director |
Oussama Abbas | - | 2020 | Non-Executive Director |
Ayesha Aziz | - | 2021 | Non-Executive Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review